A carregar...

PDE4 inhibitors: current status

Phosphodiesterase4 inhibitors are currently under development for the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease. The rationale for the development of this drug class stems from our understanding of the role of PDE4 in suppressing the function of a r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Spina, D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2567892/
https://ncbi.nlm.nih.gov/pubmed/18660825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjp.2008.307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!